ResearchMoz

Top 200 Industrial Robotics (Global)

Plimsoll Publishing Ltd.
Published Date » 2012-07-01
No. Of Pages » 305
   
This report is an in-depth financial evaluation of the GlobalIndustrial Robotics. Using the unique Plimsoll method of analysis, each of the top 200 companies included is individually assessed and ranked against each other and compared to industry averages.Using the most up-to-date financial information available, the two-page per company analysis provides detailed financial analysis for each organisation. The following are some of the key findings of this new report:     23 of the 200 companies analysed have been rated as Danger   42 companies are ripe for takeover    28 companies achieved greater than 10% increase in sales last year.   10 companies made a pre-tax loss.    70 companies saw sales fall last year ....
Table Of Contents

This extensive report is broken into two parts:


1. A complete financial assessment of the market, based on the companies analysed
2. An individual financial performance analysis of each company (2 pages per company)

Specific areas included in the market assessment include;

Section 1 - Best Trading Partners (based on commercial and financial strength)

1.1a Best Trading Partners definition and industry top 5 list
1.1b Performance matrix (Financial Strength Vs Sales Growth)
1.1c List of Best Trading Partners in the industry

Section 2 - Sales & Market Performance

2.1 Sales Growth
2.1a 4 year trend analysis
2.1b Industry Average Sales Growth
2.1c Sales Growth Ranking Table
2.1d Top 50 Companies ranked by Market Share
2.2 Sales Return on Assets
2.2a 4 year trend analysis
2.2b Sales return on total assets
2.2c Sales return on assets ranking table
2.2d Top 50 companies sales return on assets

Section 3 Profitability

3.1 Pre-tax profit margin
3.1a Pre-tax profit margin 4 year trend analysis
3.1b Industry Average pre-tax profit margin
3.1c Pre-tax profit margin ranking table
3.1d Top 50 companies actual pre-tax profit
3.2 - Pre-tax profit return on total assets
3.2a - Pre-tax profit return on total assets 4 year trend analysis
3.2b Industry average pre-tax profit return on total assets
3.2c Pre-tax profit return on total assets ranking table
3.3 - Profitability
3.3a Profitability industry average

4. 0 How to Use

5.0 Individual Company Analysis

The individual company assessment gives a complete financial picture of each company listed, including a narrative summary of the analysis. One of our key indicators is the Plimsoll Chart which combines several performance figures to give an overall measurement of the financial strength of any company. The Plimsoll chart is complied through the analysis of several different areas, including;

Sales Growth, Trading Stability, Profitability, Working Capital, Gearing and Immediate Liquidity

As all measurements are standardised, in one report you can quickly compare like with like for every major company in your industry. The accounts of each company appear in its own currency and US$ to allow comparison.

Each individual company analysis includes:

  • A full four year financial assessment, Debtor days analysis, Latest sales/profitability rankings. 
  • Employee Performance Analysis, Comparisons against industry average.
  • Overall company financial rating as read in the Plimsoll Chart, Industry ranking matrix.
  • Company analysis written summary.
Other information in the report includes;

  • Details of the Plimsoll Model
  • Definition of Terms
  • List of Shareholders
  • Global Index by region
  • Ranking Analysis by sales/profits
  • Companies considered but not included
  • Index of companies


List of Tables

NA

List of Figures

NA

Upcoming Reports:

Total Wrist Reconstruction Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Total wrist reconstruction treatment includes repair of any damaged ligament, tendon, bones or nerves in the wrist which causes pain and discomfort to the patient. Arthritis patients are more likely to suffer from wrist injuries. Rheumatoid arthritis and osteoarthritis are common categories of arthritis that increase the risk of wrist injuries. Apart from arthritis, carpel tunnel syndrome is another major reason that leads to wrist injuries.  Global aging of population, increasing incidences of arthritis and osteoporosis, increasing awareness about the available treatments for...
Nanoparticle Titanium Dioxide (Tio2) Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
By - Transparency Market Research
The strong demand for titanium dioxide Nanoparticle materials in various applications is driving this market. The major application areas of TiO2 Nanoparticles are paints and pigments, sunscreens, plastics, paper, ceramics, skin care, cosmetics, catalysts, printing inks, and glass.  According to market estimates, production of Nanoparticle titanium dioxide is around 2 million tons per year. With increased demand in the Asian market and other developing countries, it is expected that the Nanoparticle titanium dioxide market will experience significant growth in the...
Land Mobile Radio (LMR) Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018
By - Transparency Market Research
Land Mobile Radio (LMR) is used by public works organizations, field staff in large companies, emergency first responder organizations, and others wherever there is requirement of careful planning for achieving system performance. With steady recovery of organizations from economic recession, companies are continuing to invest in digital technologies for better solutions. Business organizations and governments require strong, secured, and reliable wireless communications systems for various reasons such as security purpose, enforcement, and others. LMR tools are expected to be an...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Order cancellations not a sign of market slump: Airbus
Jul 31, 2014  
Leading aircraft manufacturer Airbus on Wednesday said that the recent wave of order cancellations for its commercial jetliners do not mean that the market has declined. The market is still strong and single-aisle jets deals are likely to return later. A total of 225 Airbus cancellations were reported since the beginning of this year. Of these, Dubai’s Emirates Airlines alone...
Leading Australian Universities Want to Hike Fees, Enroll Fewer Students
Jul 31, 2014  
Australia’s prestigious group of top eight universities, also known as the Group of Eight (Go8), has indicated plans of increasing tuition fees while reducing the number of students they enroll, a reform-backer has predicted. These decisions could be made if the universities are deregulated .  Arguing for this decision, the chairman of Go8, and vice chancellor of the ANU, Ian...
Bristol-Myers Squibb Posts USD 3.9 billion Revenues in 2014 Second Quarter
Jul 30, 2014  
Leading bio-pharmaceutical company Bristol-Myers Squibb has registered revenues of USD 3.9 billion in the 2014 second quarter. This marks a 4% decrease from the same period in 2013. The global revenues of the company (excluding the divested Diabetes Alliance), saw a 7% increase. In this quarter, the company’s results were underlined by steady global sales of nearly each of its...
Novartiss Simbrinza gets approval from the EU
Jul 30, 2014  
Glaucoma patients in Europe can easily obtain Novartis’ Simbrinza eye drops which are a combination of brimonidine tartrate and brinzolamide and it is without a beta-blocker. This eye drop has got the approval of the European Commission. Unlike the inefficient treatment provided by monotherapy, this eye drop aims at treating intraocular pressure or IOP in adults with ocular hypertension...
Second Treaty Between Zealand And Boehringer Ingelheim
Jul 30, 2014  
Denmark based Pharma group Zealand Pharma and Germany’s Boehringer Ingelheim have signed an accord to formulate new medicines for advanced and effective treatment of cardio-metabolic maladies. The collaboration between these two Pharma groups involves a new therapeutic peptide project from the list of preclinical programs of Zealand Pharma.  Both these companies are aiming...